Geode Capital Management, LLC Pax Medica, Inc. Transaction History

Geode Capital Management, LLC

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	BUY	$1.42 - $3.62 $43,709 - $111,427	30,781 New	30,781 $58,000

Ticker PXMD
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,779,500
Market Cap $1.06M
Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.